New Details on the Revision of USP Chapter 1
Recommendation

Thursday, 26 November 2026 9 .00 - 17.15 h
As already reported in the news "Second Revision of USP Chapter <1> Injections and Implanted Drug Products (Parenterals)-Product Quality Tests", USP's Chapter <1> "Injections and Implanted Drug Products (Parenterals)-Product Quality Tests' has been revised again. New information is now available.
The USP published these details on 25 March. The revised version now contains a table of contents for a better overview whereas the Product Performance Test at the end of the Chapter has been deleted. All details about the new version of USP's Chapter <1> can be found on the USP website.
The revised Chapter will become effective on May 1st, 2016.
Related GMP News
27.10.2026FDA Warning Letter for a microbially contaminated Sterile Solution
07.10.2026USP Revises the Pharmaceutical Water Monographs
23.09.2026FDA criticises Visual Inspection
09.09.2026What is meant by Good Engineering Practice in the Pharmaceutical Industry?


